Back
Zevra Therapeutics Stock Predictions
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ZVRA
Zevra Therapeutics
Last Price:
$7.89
Seasonality Move:
-2.94%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Zevra Therapeutics Stock Forecast
-
Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 5.2% based on the past 10 years of stock performance.
-
Zevra Therapeutics has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Zevra Therapeutics Stock Undervalued?The current Zevra Therapeutics [ZVRA] share price is $7.75. The Score for ZVRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 5.2% based on the past 10 years of stock performance.
Zevra Therapeutics Stock Rating
Sell
37
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics overpriced?
-
Zevra Therapeutics has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Zevra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
9.76
52-Week Low:
4.20
Prediction Charts
Market Cap:
419.4M
Price in USD:
7.75
Volume:
465.4K
Beta:
1.80
Technical Analysis
SMA50:
7.55
SMA100:
7.81
SMA200:
7.86
52-Wk Change:
60.79%
Stock Predictions
-
Is Zevra Therapeutics stock public?Yes, Zevra Therapeutics is a publicly traded company.
-
What is the Zevra Therapeutics stock quote today?The Zevra Therapeutics stock price is 7.75 USD today.
-
How to buy Zevra Therapeutics stock online?You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-23 | 7.49 | 7.25 | 7.55 | 7.23 |
| Apr-24 | 7.25 | 7.24 | 7.29 | 7.01 |
| Apr-25 | 7.20 | 7.20 | 7.21 | 7.04 |
| Apr-28 | 7.22 | 7.20 | 7.26 | 7.15 |
| Apr-29 | 7.25 | 7.23 | 7.35 | 7.11 |
| Apr-30 | 7.17 | 7.33 | 7.42 | 7.15 |
| May-1 | 7.30 | 7.64 | 7.90 | 7.19 |
| May-2 | 7.71 | 8.00 | 8.10 | 7.66 |
| May-5 | 7.93 | 8.00 | 8.09 | 7.86 |
| May-6 | 7.90 | 7.40 | 8.03 | 7.40 |
| May-7 | 7.45 | 7.51 | 7.57 | 7.26 |
| May-8 | 7.50 | 7.79 | 7.96 | 7.31 |
| May-9 | 7.82 | 7.87 | 8.08 | 7.82 |
| May-12 | 8.02 | 7.75 | 8.11 | 7.72 |
Zevra Therapeutics Earnings
Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics Forecast Revenue Growth
Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.05 per share, and an increase next year of $0.48 per share.
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.